Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trial

Br J Cancer. 2024 Jan;130(1):163. doi: 10.1038/s41416-023-02520-7.
No abstract available

Publication types

  • Published Erratum